Venture
Affiliations
New York Institute of Technology
Technologies
Therapeutic
Indication
Oncology
We discovered that inhibition of FANCM prevents the survival of ALT cancers (10-15% of cancers) and planned to develop FANCM inhibitors to treat ALT cancers.
ALT therapeutics Team: